Conference Proceedings

DMXAA [ASA404], a novel tumour vascular disrupting agent under clinical investigation in lung and prostate cancers

Fredrik Erlandsson, Mark McKeage, Joachim Von Pawel, Roberto Pili, Mark Rosenthal, Gary Acton

CELLULAR ONCOLOGY | IOS PRESS | Published : 2008

University of Melbourne Researchers

Keywords

Cell Biology
Life Sciences & Biomedicine
Pathology
Oncology
Science & Technology